OBIO icon

Orchestra BioMed

23 hedge funds and large institutions have $56.4M invested in Orchestra BioMed in 2022 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 9 reducing their positions, and 43 closing their positions.

New
Increased
Maintained
Reduced
Closed

less ownership

Funds ownership:

less capital invested

Capital invested by funds: $ → $

less funds holding

Funds holding:

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

91% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 43

100% less funds holding in top 10

Funds holding in top 10: 20 (-2)

Holders
23
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

1 +$9.9M
2 +$3.89M
3 +$240K
4
Deutsche Bank
Deutsche Bank
Germany
+$149K
5
UBS Group
UBS Group
Switzerland
+$23.1K

Top Sellers

1 -$9.35M
2 -$7.97M
3 -$7.34M
4
AC
Amitell Capital
Singapore
-$5.98M
5
SC
Sculptor Capital
New York
-$5.41M
Name Holding Trade Value Shares
Change
Change in
Stake
1
$9.9M
2
$7.83M
3
$7.18M
4
$6.04M
5
$3.96M
6
$3.96M
7
$3.96M
8
$3.89M
9
$2.48M
10
$2.43M
11
$1.7M
12
$1.25M
13
$493K
14
$459K
15
$240K
16
$197K
17
$149K
18
$123K
19
$99K
20
$28K
21
$21K
22
$15K
23
$1K
24
25